Your browser doesn't support javascript.
loading
Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.
Zila, Nina; Bileck, Andrea; Muqaku, Besnik; Janker, Lukas; Eichhoff, Ossia M; Cheng, Phil F; Dummer, Reinhard; Levesque, Mitchell P; Gerner, Christopher; Paulitschke, Verena.
Afiliação
  • Zila N; 1Department of Dermatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
  • Bileck A; 2Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
  • Muqaku B; 3University of Applied Sciences (FH Campus Wien), Vienna, Austria.
  • Janker L; 2Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
  • Eichhoff OM; 2Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
  • Cheng PF; 2Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
  • Dummer R; Department of Dermatology, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Levesque MP; Department of Dermatology, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Gerner C; Department of Dermatology, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Paulitschke V; Department of Dermatology, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
Clin Proteomics ; 15: 13, 2018.
Article em En | MEDLINE | ID: mdl-29541007

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article